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LETTERS
are needed to determine the role of 
nasal carriage in B. holmesii bacte-
remia. That no B. holmesii infections 
occurred after rituximab was stopped 
suggests that rituximab played a role 
in the recurrent infections. In cases of 
recurrent infection or bacteremia, na-
sal carriage should be assessed, and 
the interruption of rituximab should 
be considered by physicians.
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Rickettsia africae 
in Amblyomma 
variegatum Ticks, 
Uganda and Nigeria
To the Editor: Rickettsia africae 
is the most widespread spotted fever 
group (SFG) rickettsia in sub-Saharan 
Africa, where it causes African tick-
bite fever (1), an acute, influenza-like 
syndrome. The number of cases in 
tourists returning from safari in sub-
Saharan Africa is increasing (1). In 
western, central, and eastern sub-Sa-
haran Africa, R. africae is carried by 
Amblyomma variegatum (Fabricius, 
1794) ticks (2); usually associated 
with cattle, this 3-host tick also can 
feed on a variety of hosts, including 
humans (2). R. africae has not been re-
ported in Uganda and rarely reported 
in Nigeria (3,4). Our objective was to 
determine the potential risk for human 
infection by screening for rickettsial 
DNA in A. variegatum ticks from cat-
tle in Uganda and Nigeria.
In February 2010, ticks were col-
lected from zebu cattle (Bos indicus) 
from 8 villages in the districts of Ka-
beramaido (Adektar [1°81′N–33°22′ 
E], Awimon [1°66′N–33°04′ E], Kalo-
bo [1°88′ N–33°25′ E], Odidip [1°90′ 
N–33°30′ E], Odikara [1°91′ N–33°30′ 
E], and Olilimo [1°75′ N–33°38′ E], 
and Dokolo (Alela [2°09′ N–33°16′ 
E], and Angeta [1°87′ N–33°10′ E]) 
in Uganda and, in June 2010, in 3 
villages (Mangar [9°14′ N–8°93′ E], 
Ruff [9°43′ N–9°10′ E], and Tambes 
[9°38′ N–9°38′ E]) in the Plateau 
State in Nigeria (Figure). This con-
venience sample was obtained as part 
of other ongoing research projects in 
both countries. Ticks were preserved 
in 70% ethanol and identified mor-
phologically to the species level by 
using taxonomic keys (5). Because the 
anatomic features do not enable an ob-
jective assessment of the feeding sta-
tus of adult male ticks, engorgement 
level was determined only in female 
tick specimens and nymphs.
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After tick identification, DNA was 
extracted from ticks by using QIAmp 
DNeasy kits (QIAGEN, Hilden, Ger-
many). Two PCR targets were assessed 
within each sample; the primer pair 
Rp.CS.877p and RpCS.1258n was se-
lective for a 396-bp fragment of a high-
ly conserved gene encoding the citrate 
synthase (gltA) shared by all Rickettsia 
spp. (6); the Rr190–70p and Rr190–
701n primer pair amplified a 629–632-
bp fragment of the gene encoding the 
190-kD antigenic outer membrane 
protein A (ompA), common to all SFG 
rickettsiae (6,7). DNA extracted from 
2 A. variegatum tick cell lines (AVL/
CTVM13 and AVL/CTVM17), previ-
ously amplified and sequenced by us-
ing primers for Rickettsia 16S rRNA, 
ompB, and sca4 genes revealing >98% 
similarity with R. africae (8), was used 
as a positive control. Negative con-
trols consisted of DNA from 2 male 
and female laboratory-reared Rhipi-
cephalus appendiculatus ticks and dis-
tilled water. DNA of positive samples 
was recovered, and confirmation of 
amplicon authenticity was obtained 
through sequence analysis by using 
nucleotide BLAST (www.ncbi.nlm.
nih.gov/BLAST).
A total of 39 ticks were collected 
in Uganda (32 adult males, 5 females, 
and 2 nymphs), and 141 were collect-
ed in Nigeria (80 males, 59 females, 
and 2 nymphs); all were identified as 
A. variegatum (online Technical Ap-
pendix Table, wwwnc.cdc.gov/EID/
articlepdfs/19/10/13-0389-Techapp1.
pdf). SFG rickettsiae DNA was am-
plified in 26 (67%) of 39 ticks from 
Uganda and 88 (62%) of 141 ticks 
from Nigeria by using the ompA gene 
primers; amplicons of the gltA genes 
were obtained in 16 (41%) of 39 ticks 
and 84 (60%) of 141 ticks, respective-
ly (online Technical Appendix Table). 
Overall, 81 (45%) of 180 ticks were 
positive by gltA and ompA PCRs (on-
line Technical Appendix Table). DNA 
sequences of the 22 gltA and ompA 
products from Uganda and the 22 
from Nigeria showed 100% similarity 
with published sequences of R. africae 
(GenBank accession nos. U59733 and 
RAU43790, respectively). For both 
countries, ticks positive for Rickettsia 
spp. and SFG rickettsiae DNA were 
male and female specimens (online 
Technical Appendix Table). Among 
females, both unengorged and en-
gorged specimens contained DNA 
from rickettsiae and SFG rickettsiae 
(online Technical Appendix Table).
These findings represent a nov-
elty for Uganda. With reference to 
Nigeria, our results contrast with 
the prevalence of 8% recorded in a 
similarly sized sample (n = 153) of 
A. variegatum ticks collected from 
cattle in the same part of the coun-
try (3); this discrepancy might be the 
result of previous targeting of the 
rickettsial 16S rDNA gene. In the 
study reported here, the SFG-specific 
ompA PCR proved to be more sensi-
tive than gltA for detecting rickettsi-
ae DNA, as has also been reported in 
previous work (9). Although finding 
R. africae DNA in engorged female 
and nymphal tick specimens might 
be attributable to prolonged rickett-
semia in cattle (10), the presence of 
R. africae in distinctly unengorged 
female ticks indicates the potential 
for A. variegatum ticks to act as a 
reservoir of this SFG rickettsia (2).
Figure.	 Location	 of	 areas	 studied	
for Rickettsia africae in Amblyomma 
variegatum	 ticks	 in	 Nigeria	 (A)	 and	
Uganda	(B),	2010.
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This study extends the known geo-
graphic range of R. africae in A. varie-
gatum ticks in sub-Saharan Africa. The 
number of potentially infective ticks re-
corded in Uganda and Nigeria suggests 
that persons in rural areas of northern 
Uganda and central Nigeria might be at 
risk for African tick-bite fever. Aware-
ness of this rickettsiosis should be 
raised, particularly among persons who 
handle cattle (e.g., herders and paravet-
erinary and veterinary personnel). Phy-
sicians in these areas as well as those 
who care for returning travelers, should 
consider African tick-bite fever in their 
differential diagnosis for patients with 
malaria and influenza-like illnesses.
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Ongoing Measles 
Outbreak in  
Orthodox Jewish 
Community,  
London, UK
To the Editor: Measles out-
breaks have been reported in Or-
thodox and ultra-Orthodox Jewish 
communities across Europe and Is-
rael (1–5). We describe an ongoing 
outbreak within the largest European 
Orthodox Jewish community (includ-
ing a Charedi population of 17,587), 
based in London, focused in Hackney 
(6). Vaccination coverage within this 
community is lower than in the gen-
eral population of London, causing 
low herd immunity and outbreaks of 
vaccine-preventable diseases. Vacci-
nation coverage data within the com-
munities cannot be extrapolated, be-
cause membership is not classified as 
an ethnicity and not collected within 
health electronic recording systems. 
However, general practice surgeries 
in Hackney known to have high pro-
portions of Orthodox Jewish patients 
have considerably lower vaccination 
coverage (55%–75% of patients 24 
months of age had received measles, 
mumps, rubella [MMR] vaccine in 
the 3rd quarter of 2012) compared 
with the London average (87.3%) (7). 
Health beliefs, family size (the aver-
age Charedi household size is 6.3 
persons), and underutilization of im-
munization services contribute to low 
coverage (8,9).
The outbreak clinical case defi-
nition was taken from Public Health 
England’s guidance (10). It also in-
cluded membership in the Orthodox 
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